To elucidate whether the activation of NF‐κB mediated the oncogenic roles of LINC01578 in colon cancer, DLD‐1 cells with LINC01578 overexpression or control were treated with NF‐κB inhibitor JSH‐23. This evidence concerns the gene NFKB1 and colonic neoplasm.